Zoetis Inc. (ZTS), the world’s leading animal health company, reported outstanding results for the second quarter of 2024 and raised its full-year guidance. The company’s revenue came in at $2.36 billion, surpassing analysts’ estimate of $2.31 billion. It posted adjusted net income per share of $1.56 for the second quarter, compared to the consensus estimate of $1.48.
The company achieved 12% revenue growth in the U.S. and 10% operational revenue growth internationally, with its companion animal and livestock portfolios showing impressive global operational growth of 12% and 9%, respectively.
